MetLife Inc. stock holds near 52-week highs as buyback and New Frontier plan shape outlook

Published on 09/10/2026 at 17:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MetLife Inc. stock ended the last completed NYSE session at USD 95.69 on September 9, 2026, sitting about 5 percent below its 52-week high. The insurer’s New Frontier strategy and a USD 3 billion buyback authorization frame the current investor story.

Moderne Glasfassade einer Versicherungszentrale bei Dämmerung mit Skyline im Hintergrund — Fotorealistische Glasfassade einer Firmenzentrale bei Dämmerung passend zu MetLife Inc. mit ISIN US59156R1086, Illustration mit AI erstellt.

MetLife Inc. stock (ISIN US59156R1086) closed at USD 95.69 on the New York Stock Exchange on September 9, 2026, leaving the shares about 5 percent below their 52-week high of USD 100.93 and roughly 42 percent above the 52-week low of USD 67.33.

Strategy update and buyback underpin MetLife narrative

The most recent completed US trading session on September 9, 2026 saw MetLife Inc. end the day at USD 95.69 after moving between an intraday low of USD 94.88 and a high of USD 96.30, keeping the stock comfortably within its 52-week range of USD 67.33 to USD 100.93.

According to MarketBeat, MetLife’s board of directors approved a share repurchase program on August 5, 2026 that authorizes the company to buy back up to USD 3,000,000,000 of its outstanding shares, adding a sizeable capital return pillar to the investment case.

The same MarketBeat overview reports that MetLife’s market capitalization stood at around USD 61.41 billion in the snapshot tied to a USD 78.45 share price and that the stock’s 52-week range runs from USD 67.33 to USD 100.93, giving investors a sense of both upside potential and downside protection in recent trading.

Recent earnings and growth metrics

For the second quarter of 2026, MetLife Inc. reported earnings per share of USD 2.43, beating the consensus estimate of USD 2.30 by USD 0.13, while revenue reached USD 13.52 billion, representing a 10.5 percent increase year over year, according to MarketBeat.

The same Q2 2026 update cited by MarketBeat indicates that MetLife generated a net margin of 4.57 percent and a return on equity of 23.39 percent for the period, underscoring a business that combines solid top-line growth with comparatively high profitability for a large insurer.

At the KBW Insurance Conference 2026 held on September 9, 2026, MetLife executives said their five-year New Frontier strategy, launched in December 2024, is running ahead of schedule, with earnings, returns and cash flow all exceeding plan, according to Investing.com.

In that conference appearance, MetLife highlighted that it delivered EPS growth of around 10 percent in fiscal year 2025, achieved an adjusted return on equity of 17 percent in fiscal year 2024, and generated nearly USD 5,000,000,000 in free cash flow in fiscal year 2025, figures that illustrate how the New Frontier plan has translated into tangible financial performance so far, according to Investing.com.

Analyst views and valuation backdrop

Analyst sentiment toward MetLife Inc. remains constructive, with MarketBeat data showing that the stock carries a Buy consensus rating and an average price target of USD 102.21, which sits about 7 percent above a referenced USD 95.45 trading level in the same overview, according to MarketBeat.

Within that analyst framework, Morgan Stanley raised its MetLife price target from USD 103.00 to USD 111.00, while Wells Fargo increased its target from USD 101.00 to USD 109.00, reflecting incremental optimism on future returns and earnings power, as reported in the same MarketBeat update.

For investors, the combination of a Buy consensus, price targets clustered slightly above the current share price and an authorized USD 3 billion buyback suggests that both external analysts and MetLife’s own board see room for continued value creation, although execution on the New Frontier strategy and macro conditions will remain key.

Macro setting and upcoming dates for MetLife stock

Broader market dynamics have also influenced MetLife’s recent trading, with the S&P 500 Index slipping around 0.5 percent on September 9, 2026 as energy costs and expectations of further Federal Reserve tightening weighed on sentiment, according to Ad-hoc-News.

That macro pressure helped explain why MetLife stock fell about 0.9 percent in the September 9, 2026 session despite the absence of a new company-specific release, with investors focusing instead on inflation dynamics, interest-rate expectations and their impact on life insurers’ investment returns, as described by Ad-hoc-News.

Looking ahead, MetLife’s next earnings date is listed as November 9, 2026 on Yahoo Finance, a checkpoint at which investors will look for confirmation that the Q2 2026 trends in revenue growth and profitability remain intact under the New Frontier strategy.

MetLife stock price context for investors

As of the last completed NYSE trading day on September 9, 2026, MetLife Inc. stock closed at USD 95.69, with the price sitting around 5 percent below the 52-week high of USD 100.93 and about 42 percent above the 52-week low of USD 67.33, positioning the shares in the upper portion of their one-year trading band.